Achelios Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $350K
Latest Deal Amount
  • Investors
  • 1

Achelios Therapeutics General Information

Description

Developer of pharmaceutical products designed to reformulate non-steroidal anti-inflammatory drug (NSAID) molecules as topically delivered medications. The company's technology focuses on therapeutic compound development for the treatment of migraine prophylaxis, osteoarthritis, sprains and strains and TMJ disorders by decreasing side effects, improving efficacy and improving time to efficacy, enabling patients to receive improved pain relief, faster.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Primary Office
  • 4364 South Alston Avenue
  • Suite 300
  • Durham, NC 27713
  • United States
+1 (919) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Achelios Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 18-Apr-2016 $350K 00.000 Completed Clinical Trials - Phase 2
3. Seed Round 13-Mar-2014 00.000 00.000 000.00 Completed Clinical Trials - Phase 2
2. Loan 19-Sep-2013 $250K $4.25M Completed Generating Revenue
1. Capitalization 02-Feb-2012 $4M $4M 0000 Completed Clinical Trials - Phase 1
To view Achelios Therapeutics’s complete valuation and funding history, request access »

Achelios Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view Achelios Therapeutics’s complete cap table history, request access »

Achelios Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of pharmaceutical products designed to reformulate non-steroidal anti-inflammatory drug (NSAID) molecules as t
Biotechnology
Durham, NC
10 As of 2020
00.000
0000000000 0 00.000

000000

dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui o
0000 000000000
Atlanta, GA
0 As of 0000
00000
0000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Achelios Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Accelerator/Incubator Backed Atlanta, GA 0 00000 0000000000 00000
To view Achelios Therapeutics’s complete competitors history, request access »

Achelios Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Crist Frangakis Ph.D Founder, President, Chief Executive Officer & Chairman
Wade Ficken Chief Financial Officer
Paul Russo Director & Board Member
Mike Fox Chief Business and Commercial Officer
John Fort MD Chief Medical Officer & Vice President of Clinical Operations
You’re viewing 5 of 7 executive team members. Get the full list »

Achelios Therapeutics Board Members (8)

Name Representing Role Since
Crist Frangakis Ph.D Achelios Therapeutics Founder, President, Chief Executive Officer & Chairman 000 0000
Jerry Rosenblatt Achelios Therapeutics Board Member 000 0000
Jon Saxe Achelios Therapeutics Board Member 000 0000
Michael Barthalomew Achelios Therapeutics Board Member 000 0000
Paul Russo Achelios Therapeutics Director & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Achelios Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Achelios Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kyto Technology And Life Science Corporation Minority 000 0000 000000 0
To view Achelios Therapeutics’s complete investors history, request access »